ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
CompanyFounded & HQStage / Raised to Date fromDescriptionProduct Category
2
BiomeSense2018 Chicago$10M incl. IndieBio, Bluestein VenturesDeveloping novel technologies to enable continuous, at-home monitoring of the human microbiome.Microbiome enabling technology
3
Clinical Microbiomics2016 CPH$10M SeventureWe help you decode the genetic and metabolic fingerprints of our microbial inhabitants to address our most urgent health challenges.Microbiome enabling technology
4
PhenoAI2021 Tel Avivn/a Entrée CapitalDeveloper of a database platform designed to provide deep-phenotype multi-omics datasets. Microbiome enabling technology
5
Cryptobiotix2021 Belgiumn/aProvider of next-gen preclinical CRO in the gastrointestinal space intended to offer in vitro digestion and ex vivo gut microbiome research services.Microbiome enabling technology
6
Holobiome2015 incorporated - 2017 operational kick-off - BostonSeed - $2M dilutive capitalThe human gut microbiome company (”The answer was inside us all along.”)The human gut microbiome company (”The answer was inside us all along.”)
7
Genbioma2019 Spainn/aMicrobiome company dedicated to making people healthier through microbiome-targeted solutions.Microbiome therapeutics - pharma and consumer (probiotic supplement for prediabetics)
8
Kallyope2015 NYCBill & Melinda Gates FoundationAim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases.Microbiome therapeutics - pharma (neuro, metabolism, GI)
9
Axial Biotherapeutics2016 US$110M incl. Seventure, Kairos VenturesClinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.Microbiome therapeutics - pharma (gut<>brain focus)
10
Kaleido Biosciences2015 US$217 incl. Olive Tree Capital, liquidated in 2022Focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Microbiome therapeutics - pharma
11
PharmaBiome2015 Zurich SwitzerlandCHF 2MTechnologies to access the entire range of intestinal bacteria for the design and production of function-based consortia at scale.Microbiome therapeutics - pharma
12
AsiaBiome2018 US / HK$0.15M before being acquired by Holobiome in 2022Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics.Microbiome therapeutics - pharma
13
Finch Therapeutics2017 MA US$188M before going public in March 2021Microbiome development company that serve patients with serious unmet medical needs.Microbiome therapeutics - pharma
14
Maat Pharma2014 France€31M incl. SeventureClinical-stage microbiome therapeutics company aiming to improve survival in cancerMicrobiome therapeutics - pharma (oncology)
15
Microbiotica2016 Cambridge UKGBP 26M incl. Tencent, SeventureDeveloper of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkersMicrobiome therapeutics - pharma
16
Enterome2012 France€175M incl. Nestlé, SeventureClinical stage cancer treatments.Microbiome therapeutics - pharma
17
Seres Therapeutics2010 MA US$527M incl. Mayo Clinic, Nestlé (now public)Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics.Microbiome therapeutics - pharma
18
Vedanta Biosciences2010 MA US$433 incl. PfizerA New Class of Drugs to Modulate the Human MicrobiomeMicrobiome therapeutics - pharma
19
Evelo Biosciences2014 MA USLiquidated Nov. 2023Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine.Microbiome therapeutics - pharma
20
Azitra2014 US $37M incl. Leaps by Bayer (now public)Precision dermatology powered by microbial and genetic engineering.Microbiome therapeutics - pharma (skin)
21
AOBiome2013 MA US$105M incl. Wild VenturesLive topical biotherapeutics for the treatment of inflammatory skin disorders.Microbiome therapeutics - pharma (skin)
22
SNIPR Biome2017 CPH$53M incl. EQT Lifesciences, Wellington PartneraWe are pioneering CRISPR-based microbial gene therapy.Microbiome therapeutics - pharma
23
BiomX Inc.2015 Israel$81M incl. Seventure (now public)Customized phage therapies to eradicate harmful bacteria in chronic diseases.Microbiome therapeutics - pharma
24
Eligo Bioscience2014 Paris$69M incl. Sanofi, Khosla, SeventureGene-editing focused on addressing diseases driven by the expression of bacterial genes from the microbiome.Microbiome therapeutics - pharma
25
Ombre2016 SFn/aOmbre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.Microbiome insights / Health Test Providers
26
DayTwo2015 California$90M incl. J&J, MayoClinic, Seventure, Cathay Innovation, Samsung NextPrecision nutrition for metabolic disease using gut microbiome science, AI and virtual clinical support.Microbiome insights / Health Test Providers
27
Viome2016 Washington$210 incl. Bulletproof Media, Squareone CapitalOperator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases. Microbiome insights / Health Test Providers
28
Zoe2017 London$107M incl. Balderton, Ahren Innovation, DaphniProvider of medical testing services intended to deliver recommendations on personalized dietary plans for individuals. Microbiome insights / Health Test Providers
29
Biomes 2017 Germany, MexicoRaised $8M, liquidated in 2022Manufacturer of probiotics and tests designed to improve individual life through precision nutrition & health prevention. Microbiome insights / Health Test Providers
30
Microba2017 AustraliaPublic (ASX:MAP)Commercial-stage company with technology for measuring the human gut microbiome Microbiome insights / Health Test Providers
31
Floré2016 San Diego $27M incl. IndieBio, Plug and Play, Pngaea VenturesProvider of gut test and custom probiotics intended for improving gut health.Microbiome insights / Health Test Providers
32
Biohm Health2016 US$8M incl. Aztec CapitalManufacturer of gut health products and kits intended to help people understand their gut microbiome. Microbiome insights / Health Test Providers
33
TargEDys2015 France$10M Seventure, PontifaxDeveloper of microbe mechanism designed to control the metabolic disease by modulating the appetite through intervention.Food & biopharma
34
OneBio2019 Sacramento$17M iSelect, Seventure, Collab Fundone.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.Food & biopharma
35
Siolta Therapeutics2016 California$30M incl. GlobalBrain, Marc Benioff, Seventure, KhoslaClinical-stage biopharmaceutical company developing novel targeted live biotherapeutic products (LBPs) to prevent and treat diseases of high unmet medical need.Food & biopharma
36
Akkermansia Company2016 Belgium$19M incl. SeventureDeveloper of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacteriumFood & biopharma
37
Seed Health2015 LA$43M incl. Collab. Fund, 8VC, Founders Fund, GreycroftDeveloper of health supplements intended to implement applications of bacteria to impact human and environmental health. Probiotic Providers
38
Immune Biotech2013 Sweden$2.7M incl. EU and Hampus Jakobsson (GP Pale Blue Dot)Developer of novel therapeutics designed to target the gut microbiota and the immune system.Probiotic Providers
39
Resbiotic2020 Birmingham$2.6M incl. First Avenue VenturesDeveloper of probiotic therapies intended to restore a healthy lung microbiome.Probiotic Providers
40
Fitbiomics2015 NY$4.5M incl. Builders VCDeveloper of a novel probiotic bacteria biotechnology designed to be used for sports performance and recovery. Probiotic Providers
41
MYBACS2018 Munich, Germany$5.9M incl. WENVEST, GFC, Joyance PartnersSynbiotic dietary supplements, personalized and adapted to the different needs of the customers while being gluten-free, lactose-free and free of any chemical side effects.Probiotic Providers
42
Unlocked2020 US $0.5M incl. IndieBio, AstanorDeveloper of a probiotic supplement designed to help people detox their bodies. Probiotic Providers
43
Pendulum2013 SF$122M incl. Khosla, Sequoia, DCVC, Mayo ClinicDeveloper of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackling type 2 diabetes.Probiotic Providers
44
Isovive2013 US$12.6 incl. Plug and Play, Alumni VenturesDeveloper of microbiome products intended to support human gut health.Probiotic Providers
45
Nouri2018 US>$0.5M EY Ventures GroupProducer of probiotic supplements intended to improve gut health and also offer benefits to the body in specific ways. Probiotic Providers
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100